Rush offers a multidisciplinary team of doctors who are experts in the care of neuroendocrine tumors.
Rush was the first hospital in Illinois to use a detailed diagnostic test for neuroendocrine tumors, the 68-Gallium DOTATATE PET CT. It was also the first hospital in the state to offer peptide receptor radionuclide therapy (PRRT), a recently approved treatment for GI and pancreatic neuroendocrine tumors.
Rush offers neuroendocrine tumor care at locations throughout Chicago, Oak Park, and Lisle. Contact Rush online or call (312) CANCER-1.